Neurensin-2 Activators
Neurensin-2 Activators consist of chemical compounds that can affect various neuronal pathways and processes to enhance the function of Neurensin-2. Compounds such as Forskolin and Rolipram lead to an increase in cAMP levels, which subsequently enhances PKA activity. PKA can phosphorylate neuronal proteins that interact with Neurensin-2, potentially enhancing its neuronal functions. Similarly, Picrotoxin, by antagonizing GABA_A receptors, increases neuronal excitability, possibly leading to a rise in calcium influx and activation of calcium-dependent signaling pathways that indirectly enhance Neurensin-2 function. BAY K8644 directly increases intracellular calcium by agonizing L-type calcium channels, subsequently activating calcium-dependent kinases that might target proteins associated with Neurensin-2, enhancing its role in neuronal signaling.
Additionally, chemicals like Tetrodotoxin, which modifies neuronal activity by blocking voltage-gated sodium channels, could shift neuronal signaling patterns that enhance Neurensin-2 function indirectly. K252a and Anisomycin, through their roles in modulating kinases and activating stress response pathways, respectively, have the potential to upregulate compensatory pathways or stress-induced mechanisms that could lead to enhanced Neurensin-2 function. Ouabain, by inhibiting the Na+/K+ ATPase, increases neuronalexcitability, which can indirectly enhance Neurensin-2 activity by promoting intracellular signaling cascades. KN-93, by inhibiting CaMKII, may lead to a reconfiguration of calcium signaling dynamics, potentially enhancing Neurensin-2 activation through alternative pathways. Nifedipine and Nimodipine, as L-type calcium channel blockers, contribute to the modulation of calcium influx, which can indirectly influence the function of Neurensin-2 by altering downstream signaling pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels in the cell. Elevated cAMP can enhance protein kinase A (PKA) activity, which can phosphorylate neuronal substrates that may interact with Neurensin-2, enhancing its neuronal function. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4 (PDE4), leading to increased cAMP levels. This accumulation promotes PKA activity which could phosphorylate proteins associated with Neurensin-2, potentially enhancing its function. | ||||||
Picrotoxin | 124-87-8 | sc-202765 sc-202765A sc-202765B | 1 g 5 g 25 g | $67.00 $286.00 $1326.00 | 11 | |
Picrotoxin is a GABA_A receptor antagonist. Inhibition of this receptor can lead to increased neuronal firing and calcium influx, which may indirectly enhance Neurensin-2 function through calcium-dependent signaling pathways. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
BAY K8644 is an L-type calcium channel agonist, which increases intracellular calcium. Elevated calcium can activate calcium-dependent kinases that may phosphorylate and enhance the function of Neurensin-2 in neurons. | ||||||
K-252a | 99533-80-9 | sc-200517 sc-200517B sc-200517A | 100 µg 500 µg 1 mg | $129.00 $214.00 $498.00 | 19 | |
K252a is a kinase inhibitor that can modulate intracellular signaling cascades. By inhibiting certain kinases, K252a may upregulate compensatory pathways that enhance Neurensin-2 function. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that activates stress response pathways. This activation can lead to the enhancement of Neurensin-2 function via stress-induced signaling mechanisms. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain is a Na+/K+ ATPase inhibitor. By disrupting ion gradients, it can lead to increased neuronal excitability and intracellular signaling events that enhance Neurensin-2 function. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is an inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII). Inhibition of CaMKII can shift the balance of calcium signaling, potentially enhancing Neurensin-2 activity through alternative calcium-dependent pathways. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine is an L-type calcium channel blocker. By modulating calcium influx, it can indirectly influence intracellular signaling pathways that enhance Neurensin-2 function in neurons. | ||||||
Nimodipine | 66085-59-4 | sc-201464 sc-201464A | 100 mg 1 g | $61.00 $307.00 | 2 | |
Nimodipine, another L-type calcium channel blocker, may have similar effects to nifedipine, enhancing Neurensin-2 function by altering calcium-dependent signaling pathways. | ||||||